HCPCS Level II · Drugs administered other than oral method
J8520Capecitabine, oral, 150 mg
Terminated 09/30/2024
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About J8520
J8520 is an HCPCS Level II code in the J series (drugs administered other than oral method), describing capecitabine, oral, 150 mg.
It was added to HCPCS effective 01/01/2000, and its current record took effect 10/01/2024.
It was terminated on 09/30/2024 and can't be billed for later dates of service.
Its Medicare coverage code is "D", meaning special Medicare coverage instructions apply.
Details
- Short description
- Capecitabine, oral, 150 mg
- Date added
- 01/01/2000
- Action effective
- 10/01/2024
- Termination date
- 09/30/2024
- BETOS
- O1D
Related J85xx codes
- J8501Aprepitant, oral, 5 mg
- J8502Injection, aprepitant (aponvie), 1 mg
- J8510Busulfan; oral, 2 mg
- J8515Cabergoline, oral, 0.25 mg
- J8522Capecitabine, oral, 50 mg
- J8530Cyclophosphamide; oral, 25 mg
- J8540Dexamethasone, oral, 0.25 mg
- J8541Dexamethasone (hemady), oral, 0.25 mg
- J8560Etoposide; oral, 50 mg
- J8565Gefitinib, oral, 250 mg
- J8597Antiemetic drug, oral, not otherwise specified
Common questions about J8520
Is HCPCS J8520 still valid?
- No. J8520 was terminated on 09/30/2024.
Does Medicare cover J8520?
- Its coverage code is "D": special Medicare coverage instructions apply. Check the local coverage determination for your region.